Flex Pharma (FLKS) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- Wall St set for muted open as tech stocks take a breather
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Stifel sees AI supply constraints ahead of Q3 tech earnings
Flex Pharma Reports Second Quarter 2017 Financial Results
August 2, 2017 7:30 AM EDT
-- FLX-787 Granted Fast Track Designation for ALS --
--
US Phase 2 ALS Trial Initiated under IND --
-- US Phase 2
CMT Trial Commencing Third Quarter --
Conference Call
Scheduled Today at 8:45 a.m. ET
BOSTON--(BUSINESS WIRE)-- Click to Tweet
... More



